Girl2Girl: A Web-based Trial (G2G)

A Reproductive Health Program for A Select Population

This is a pilot effectiveness study of Girl2Girl, a text messaging-based pregnancy prevention program for cisgender sexual minority adolescents.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

An estimated one in four teen women will become pregnant by the time she is 20 years of age. That said, significant disparity in rates exist for lesbian, gay, bisexual and other sexual minority women (LGB) versus non-LGB teen women: Research suggests that lesbian and bisexual teen women are between two and four times more likely to report having been pregnant than teen women who identified as exclusively heterosexual. Despite this compelling evidence that lesbian and bisexual adolescent women are at risk for teen pregnancy, programs tailored to the unique needs of adolescent LGB women are nonexistent. Evidence-based teen pregnancy prevention (TPP) programs targeting LGB teen women are urgently needed.

The Girl2Girl intervention text messaging-based TPP program designed specifically for LGB women ages 14-18 years, nation-wide. This is an extension of a previous randomized controlled trial. Here, the cohort was recruited using an effectiveness strategy: Girls were allowed to register and enroll themselves without needing to talk to research staff. All eligible and interested youth were allowed to enroll; no diversity targets were applied.

Study Type

Interventional

Enrollment (Anticipated)

574

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Clemente, California, United States, 92672
        • Center for Innovative Public Health Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Endorse a non-heterosexual sexual identity (i.e., lesbian/gay, bisexual, queer, questioning, unsure) on the screener;
  • Be cisgender (i.e., be assigned a female sex at birth and endorse a female gender identity) on the screener;
  • Be aged 14-18;
  • Be English speaking;
  • Be able to provide informed assent, including the self-directed self-safety assessment.

Exclusion Criteria:

  • Not passing the self-directed self-safety assessment
  • Knowing someone who is already enrolled in the program (added part-way through the recruitment period)
  • Non-cisgender identity in the screener

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Girl2Girl
Girls receive text messages that address the information, motivation, and behavioral skills components need to prevent unwanted pregnancy.
The program has a 'core' 7 weeks of daily messages and then a week 'booster' that is delivered 3 months later.
No Intervention: Control - Healthy lifestyle
Girls receive text messages about a 'healthy lifestyle', including healthy social media use and self-esteem.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Condom protected penile-vaginal Sex Acts
Time Frame: 3-months post-intervention
The relative difference of protected penile-vaginal sex acts in the intervention versus control group at 3-months post-intervention
3-months post-intervention
Number of Participants Who Used Other Birth Control Methods
Time Frame: 3-months post-intervention
The relative difference of teens who used birth control methods other than condoms (e.g., the pill, the patch) in the intervention versus control group at 3-months post-intervention
3-months post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Testing for HIV and other sexually transmitted infections (STIs)
Time Frame: 3-months post intervention
The relative odds of reporting an HIV or other STI test during the observation period for those in the intervention versus control
3-months post intervention
Pregnancy
Time Frame: 3-months post intervention
The percent of teens who have been pregnant since the beginning of the observation period in the intervention versus control group
3-months post intervention
Intentions to use condoms
Time Frame: 3-months post intervention
The percent of teens who intend to use condoms if they have penile-vaginal sex in the future
3-months post intervention
Intentions to Use Birth Control Other Than Condoms
Time Frame: 3-months post intervention
The percent of teens who intend to use birth control other than condoms if they have penile-vaginal sex in the future
3-months post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2020

Primary Completion (Anticipated)

June 7, 2021

Study Completion (Anticipated)

June 7, 2021

Study Registration Dates

First Submitted

March 18, 2021

First Submitted That Met QC Criteria

March 19, 2021

First Posted (Actual)

March 22, 2021

Study Record Updates

Last Update Posted (Actual)

March 22, 2021

Last Update Submitted That Met QC Criteria

March 19, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • R01HD095648 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Prevention

Clinical Trials on Girl2Girl

Subscribe